Open AccessMP04-17 BURDEN OF SYSTEMIC COMORBIDITIES USING THE ACTIONS PHENOTYPE PREDICTS DISCONTINUATION OF UROLOGIC MEDICATIONS FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE
Author(s) -
JJ Zhang,
Bradley Gill,
Lamont Wilkins,
Rathika Ramkumar,
Daniel A. Shoskes
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.02.167
Subject(s) - medicine , comorbidity , discontinuation , prostate , international prostate symptom score , lower urinary tract symptoms , transurethral resection of the prostate , diabetes mellitus , hyperplasia , quality of life (healthcare) , urology , endocrinology , cancer , nursing
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom